Early Access — free while we kick the tires
EdgarHawk

Cohen Joshua B

Co-Chief Executive Officer

Director Officer
1 filing analyzed · 1 company · Latest 2026-01-20

Companies

Company Buys Sells Direction
Amylyx Pharmaceuticals, Inc. AMLX 0 4 Net selling

Activity

January 2026
high
Sell
138,167 shares
$1,878,094
Significance 6/10

AMLX Co-CEO Cohen sold 138,167 shares ($1.9M) at $13.59–$13.83; holds 3.38M shares post-sale as stock hits 52-week high of $16.55.

Co-Chief Executive Officer Joshua B Cohen executed 2 separate sales totaling 138,167 shares for $1,878,093.81 on January 15–16, 2026, at prices of $13.59 and $13.83. The current stock price of $16.55 is at the 52-week high, representing a +37.7% move over 30 days and +11.7% over 90 days. This sale reduces Cohen's holdings by 3.9% from 3,517,632 shares to 3,379,465 shares, but he retains substantial equity stake as Co-CEO. Notably, the company reported $0.00 revenue in its latest quarter and a net loss of $-34,386,000.00 for its most recent full fiscal year, with annual revenue declining -77.1%. The sale occurred as the stock neared or reached its 52-week peak, while the underlying business remains unprofitable with severely contracted revenues.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access